Literature DB >> 21309195

Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care.

Alexandra G Eller1, Michele A Bennett, Margarita Sharshiner, Carol Masheter, Andrew P Soisson, Mark Dodson, Robert M Silver.   

Abstract

OBJECTIVE: To compare maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team with similar cases managed by standard obstetric care.
METHODS: This was a retrospective cohort study of all cases of placenta accreta identified in the State of Utah from 1996 to 2008. Cases of placenta accreta were identified using International Classification of Diseases (ICD-9) codes for placenta accreta, placenta previa, and cesarean hysterectomy. Maternal morbidity was compared for cases managed by a multidisciplinary care team in two tertiary care centers and similar cases managed at 26 other hospitals using multivariable logistic regression analysis.
RESULTS: One-hundred forty-one cases of placenta accreta were identified including 79 managed by a multidisciplinary care team and 62 cases managed by standard obstetric care. Women managed by a multidisciplinary care team were less likely to require large-volume blood transfusion (4 or more units of packed red blood cells) (43% compared with 61%, P=.031) and reoperation within 7 days of delivery for bleeding complications (3% compared with 36%, P<.001) compared with women managed by standard obstetric care. Women with suspected placenta accreta managed by a multidisciplinary team were less likely to experience composite early morbidity (prolonged maternal admission to the intensive care unit, large-volume blood transfusion, coagulopathy, ureteral injury, or early reoperation) than women managed by standard obstetric care (47% compared with 74%, P=.026). The odds ratio of composite early morbidity in women managed by a multidisciplinary team was 0.22, (95% confidence interval, 0.07- 0.70) in the multivariable model.
CONCLUSION: Maternal morbidity is reduced in women with placenta accreta who deliver in a tertiary care hospital with a multidisciplinary care team. LEVEL OF EVIDENCE: II

Entities:  

Mesh:

Year:  2011        PMID: 21309195     DOI: 10.1097/AOG.0b013e3182051db2

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  41 in total

Review 1.  Urological Manifestations of Placenta Percreta.

Authors:  Mina A Ibrahim; Angela Liu; Amanda Dalpiaz; Richard Schwamb; Kelly Warren; Sardar A Khan
Journal:  Curr Urol       Date:  2015-07-10

2.  Massive blood transfusion during hospitalization for delivery in New York State, 1998-2007.

Authors:  Jill M Mhyre; Alexander Shilkrut; Elena V Kuklina; William M Callaghan; Andreea A Creanga; Sari Kaminsky; Brian T Bateman
Journal:  Obstet Gynecol       Date:  2013-12       Impact factor: 7.661

3.  Patterns of recurrence of postpartum hemorrhage in a large population-based cohort.

Authors:  Anna Sara Oberg; Sonia Hernandez-Diaz; Kristin Palmsten; Catarina Almqvist; Brian T Bateman
Journal:  Am J Obstet Gynecol       Date:  2013-10-26       Impact factor: 8.661

Review 4.  Expanding the field of acute care surgery: a systematic review of the use of resuscitative endovascular balloon occlusion of the aorta (REBOA) in cases of morbidly adherent placenta.

Authors:  R Manzano-Nunez; M F Escobar-Vidarte; M P Naranjo; F Rodriguez; P Ferrada; J D Casallas; C A Ordoñez
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-19       Impact factor: 3.693

5.  A comprehensive severity score for the morbidly adherent placenta: combining ultrasound and magnetic resonance imaging.

Authors:  Jordan C Knight; Stephen Lehnert; Anthony L Shanks; Lamia Atasi; Lisa R Delaney; Megan B Marine; Sherrine A Ibrahim; Brandon P Brown
Journal:  Pediatr Radiol       Date:  2018-09-03

6.  Risk of Peripartum Hysterectomy and Center Hysterectomy and Delivery Volume.

Authors:  Shravya Govindappagari; Jason D Wright; Cande V Ananth; Yongmei Huang; Mary E DʼAlton; Alexander M Friedman
Journal:  Obstet Gynecol       Date:  2016-12       Impact factor: 7.661

7.  Enhanced expression of αVβ3 integrin in villus and extravillous trophoblasts of placenta accreta.

Authors:  Omer Weitzner; Chen Seraya-Bareket; Tal Biron-Shental; Ami Fishamn; Yael Yagur; Keren Tzadikevitch-Geffen; Sivan Farladansky-Gershnabel; Debora Kidron; Martin Ellis; Osnat Ashur-Fabian
Journal:  Arch Gynecol Obstet       Date:  2020-10-28       Impact factor: 2.344

8.  Are women antenatally diagnosed with abnormally invasive placenta receiving optimal management in England? An observational study of planned place of delivery.

Authors:  Will Sargent; Sally L Collins
Journal:  Acta Obstet Gynecol Scand       Date:  2018-11-15       Impact factor: 3.636

9.  Retrospective Analysis of Eighty-Nine Caesarean Section Cases with Abnormal Placental Invasion.

Authors:  Feride Karacaer; Ebru Biricik; Murat Ilgınel; Demet Tunay; Mete Sucu; Hakkı Ünlügenç
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-01-18

Review 10.  Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel.

Authors:  Jonathan L Hecht; Rebecca Baergen; Linda M Ernst; Philip J Katzman; Suzanne M Jacques; Eric Jauniaux; T Yee Khong; Leon A Metlay; Liina Poder; Faisal Qureshi; Joseph T Rabban; Drucilla J Roberts; Scott Shainker; Debra S Heller
Journal:  Mod Pathol       Date:  2020-05-15       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.